Animal Biotechnology Market
授權報價
| Single User License | $4,500 USD |
| Multiple User License | $5,500 USD |
| Custom Research License | $8,000 USD |
完整報告名稱與涵蓋範圍
Animal Biotechnology Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product Type (Diagnostics Tests, Vaccines, Drugs, Reproductive and Genetic, Feed Additives), By Application (Diagnosis of Animal Diseases, Treatment of Animal Diseases, Preventive Care of Animals, Drug Development, Others), By Animal Type (Companion, Livestock), By End-use (Laboratories, Point-of-care testing/In-house Testing, Veterinary Hospitals & Clinics, Others), By Region & Competition, 2021-2031F
報告摘要
Market Overview
The Global Animal Biotechnology Market is projected to expand from USD 25.93 Billion in 2025 to USD 45.29 Billion by 2031, registering a compound annual growth rate of 9.74%. This sector applies molecular biology and genetic engineering principles to alter the genomes of terrestrial and aquatic species for the creation of agricultural, industrial, and pharmaceutical products. A key force propelling this market is the rising global demand for high-quality animal protein, which necessitates biotechnological interventions to improve disease resistance and livestock productivity. Additionally, the industry is driven by an increasing focus on sustainable food security, encouraging the development of animals that require fewer resources and have a reduced environmental impact. Highlighting this need, the Food and Agriculture Organization reported that global meat production grew by 1.7% to 379 million tonnes in 2024, emphasizing the urgency for advanced biotechnological solutions to meet this escalating supply requirement.
A major obstacle potentially hindering the growth of the global animal biotechnology market is the complicated and often fragmented regulatory environment for genetically engineered animals. Differing ethical standards and inconsistent approval processes across various international jurisdictions create significant trade barriers and slow down the commercialization of innovative products. This regulatory uncertainty increases the capital and time needed for development, which can discourage investment and effectively stall the wider adoption of new technologies within the industry.
Market Driver
The growth of the companion animal healthcare and wellness sector serves as a primary catalyst for market progression, fueled by the increasing humanization of pets. As owners place greater importance on the longevity and quality of life of their animals, there is a distinct shift toward precision medicine, requiring advanced biotechnological interventions such as genetic screening and monoclonal antibody therapies. This demand prompts biotechnology firms to adapt human-grade medical technologies for veterinary use, opening up profitable avenues for industry expansion. For instance, the American Pet Products Association revealed in its March 2024 'State of the Industry' presentation that total U.S. pet industry expenditures hit $147.4 billion in 2023, indicating a robust consumer willingness to invest in animal well-being that directly supports the research and commercialization of specialized biopharmaceuticals.
Furthermore, government initiatives and funding for veterinary biotechnology research and development strengthen the market's trajectory by mitigating risks associated with early-stage innovation and infrastructure development. Public sector grants are crucial for advancing complex technologies like gene editing and synthetic biology, which often face high financial hurdles before becoming commercially viable. Illustrating this support, UK Research and Innovation announced in February 2024 a £100 million investment to fund six new Engineering Biology Mission Hubs aimed at addressing global challenges, including those in food systems. These strategic investments allow private entities to scale operations and bring scientific breakthroughs to the global market more efficiently, a potential evidenced by Zoetis Inc., which reported revenue of $8.5 billion for the full year 2023 in its February 2024 financial results.
Market Challenge
The intricate and often disjointed regulatory landscape governing genetically engineered animals constitutes a formidable barrier to the growth of the global animal biotechnology market. Disparate approval processes and varying ethical guidelines across international jurisdictions create significant trade hurdles, forcing companies to navigate a patchwork of compliance requirements that delays commercialization. This lack of harmonization increases the financial risk for developers, who must invest substantial resources without the guarantee of global market access, thereby deterring venture capital and stifling innovation.
The extended timelines associated with these regulatory burdens further exacerbate the challenge, as companies cannot quickly recoup their investments. According to the Animal Health Institute, in 2024, the development of a new livestock pharmaceutical required an average of 8.5 years and an investment of approximately $30.5 million. Such prolonged duration and high capital expenditure prevent smaller biotech firms from entering the sector and slow the overall adoption of advanced animal health solutions essential for meeting global productivity demands.
Market Trends
The widespread adoption of CRISPR-Cas9 and precision genome editing is transitioning from experimental phases to commercial reality, fundamentally altering livestock disease management strategies. This trend is exemplified by the regulatory progression of gene-edited animals designed to resist devastating viral pathogens, thereby reducing economic losses and minimizing the industry's reliance on pharmaceuticals. A pivotal market milestone occurred when regulatory bodies began clearing these engineered traits for the food supply chain, validating the technology's safety and utility. According to Genus plc, April 2025, in the 'PRRS Resistant Pig - FDA Approval' announcement, the U.S. Food and Drug Administration approved the company's PRRS-resistant pig, a development crucial for addressing a disease that increases the need for antibiotics by more than 200% in affected herds.
Concurrently, the sector is witnessing a decisive shift toward DNA and mRNA-based veterinary vaccine platforms, driven by the urgent need for rapid response capabilities against transboundary animal diseases. Companies are aggressively capitalizing specialized manufacturing infrastructure to support these complex biologics, moving away from slower, traditional vaccine production methods. This focus on advanced large-molecule production capacity is critical for scaling novel therapeutic and preventative solutions to meet global demand. According to Merck Animal Health, May 2025, in the 'Merck Animal Health and State of Kansas Announce $895 Million Investment' press release, the company allocated $895 million to expand its facility in De Soto, Kansas, specifically to enhance filling and freeze-drying capacity for large molecule vaccines and biologic products.
Key Market Players
* Zoetis Inc
* Boehringer Ingelheim GmbH
* Biogenesis Bago SA
* Merck & Co., Inc.
* Virbac SA
* Elanco LLC
* IDEXX Laboratories Inc
* Heska Corp
* Indian Immunologicals Ltd
* Hester Biosciences Limited
Report Scope
In this report, the Global Animal Biotechnology Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
# Animal Biotechnology Market, By Product Type
* Diagnostics Tests
* Vaccines
* Drugs
* Reproductive and Genetic
* Feed Additives
# Animal Biotechnology Market, By Application
* Diagnosis of Animal Diseases
* Treatment of Animal Diseases
* Preventive Care of Animals
* Drug Development
* Others
# Animal Biotechnology Market, By Animal Type
* Companion
* Livestock
# Animal Biotechnology Market, By End-use
* Laboratories
* Point-of-care testing/In-house Testing
* Veterinary Hospitals & Clinics
* Others
# Animal Biotechnology Market, By Region
* North America
United States
Canada
Mexico
* Europe
France
United Kingdom
Italy
Germany
Spain
* Asia Pacific
China
India
Japan
Australia
South Korea
* South America
Brazil
Argentina
Colombia
* Middle East & Africa
South Africa
Saudi Arabia
UAE
Competitive Landscape
Company Profiles: Detailed analysis of the major companies present in the Global Animal Biotechnology Market.
Available Customizations:
Global Animal Biotechnology Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:
Company Information
* Detailed analysis and profiling of additional market players (up to five).
目錄 Table of Contents
1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. Voice of Customer
5. Global Animal Biotechnology Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Product Type (Diagnostics Tests, Vaccines, Drugs, Reproductive and Genetic, Feed Additives)
5.2.2. By Application (Diagnosis of Animal Diseases, Treatment of Animal Diseases, Preventive Care of Animals, Drug Development, Others)
5.2.3. By Animal Type (Companion, Livestock)
5.2.4. By End-use (Laboratories, Point-of-care testing/In-house Testing, Veterinary Hospitals & Clinics, Others)
5.2.5. By Region
5.2.6. By Company (2025)
5.3. Market Map
6. North America Animal Biotechnology Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Product Type
6.2.2. By Application
6.2.3. By Animal Type
6.2.4. By End-use
6.2.5. By Country
6.3. North America: Country Analysis
6.3.1. United States Animal Biotechnology Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Product Type
6.3.1.2.2. By Application
6.3.1.2.3. By Animal Type
6.3.1.2.4. By End-use
6.3.2. Canada Animal Biotechnology Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Product Type
6.3.2.2.2. By Application
6.3.2.2.3. By Animal Type
6.3.2.2.4. By End-use
6.3.3. Mexico Animal Biotechnology Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Product Type
6.3.3.2.2. By Application
6.3.3.2.3. By Animal Type
6.3.3.2.4. By End-use
7. Europe Animal Biotechnology Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Product Type
7.2.2. By Application
7.2.3. By Animal Type
7.2.4. By End-use
7.2.5. By Country
7.3. Europe: Country Analysis
7.3.1. Germany Animal Biotechnology Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Product Type
7.3.1.2.2. By Application
7.3.1.2.3. By Animal Type
7.3.1.2.4. By End-use
7.3.2. France Animal Biotechnology Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Product Type
7.3.2.2.2. By Application
7.3.2.2.3. By Animal Type
7.3.2.2.4. By End-use
7.3.3. United Kingdom Animal Biotechnology Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Product Type
7.3.3.2.2. By Application
7.3.3.2.3. By Animal Type
7.3.3.2.4. By End-use
7.3.4. Italy Animal Biotechnology Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Product Type
7.3.4.2.2. By Application
7.3.4.2.3. By Animal Type
7.3.4.2.4. By End-use
7.3.5. Spain Animal Biotechnology Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Product Type
7.3.5.2.2. By Application
7.3.5.2.3. By Animal Type
7.3.5.2.4. By End-use
8. Asia Pacific Animal Biotechnology Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Product Type
8.2.2. By Application
8.2.3. By Animal Type
8.2.4. By End-use
8.2.5. By Country
8.3. Asia Pacific: Country Analysis
8.3.1. China Animal Biotechnology Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Product Type
8.3.1.2.2. By Application
8.3.1.2.3. By Animal Type
8.3.1.2.4. By End-use
8.3.2. India Animal Biotechnology Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Product Type
8.3.2.2.2. By Application
8.3.2.2.3. By Animal Type
8.3.2.2.4. By End-use
8.3.3. Japan Animal Biotechnology Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Product Type
8.3.3.2.2. By Application
8.3.3.2.3. By Animal Type
8.3.3.2.4. By End-use
8.3.4. South Korea Animal Biotechnology Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Product Type
8.3.4.2.2. By Application
8.3.4.2.3. By Animal Type
8.3.4.2.4. By End-use
8.3.5. Australia Animal Biotechnology Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Product Type
8.3.5.2.2. By Application
8.3.5.2.3. By Animal Type
8.3.5.2.4. By End-use
9. Middle East & Africa Animal Biotechnology Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Product Type
9.2.2. By Application
9.2.3. By Animal Type
9.2.4. By End-use
9.2.5. By Country
9.3. Middle East & Africa: Country Analysis
9.3.1. Saudi Arabia Animal Biotechnology Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Product Type
9.3.1.2.2. By Application
9.3.1.2.3. By Animal Type
9.3.1.2.4. By End-use
9.3.2. UAE Animal Biotechnology Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Product Type
9.3.2.2.2. By Application
9.3.2.2.3. By Animal Type
9.3.2.2.4. By End-use
9.3.3. South Africa Animal Biotechnology Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Product Type
9.3.3.2.2. By Application
9.3.3.2.3. By Animal Type
9.3.3.2.4. By End-use
10. South America Animal Biotechnology Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Product Type
10.2.2. By Application
10.2.3. By Animal Type
10.2.4. By End-use
10.2.5. By Country
10.3. South America: Country Analysis
10.3.1. Brazil Animal Biotechnology Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Product Type
10.3.1.2.2. By Application
10.3.1.2.3. By Animal Type
10.3.1.2.4. By End-use
10.3.2. Colombia Animal Biotechnology Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Product Type
10.3.2.2.2. By Application
10.3.2.2.3. By Animal Type
10.3.2.2.4. By End-use
10.3.3. Argentina Animal Biotechnology Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Product Type
10.3.3.2.2. By Application
10.3.3.2.3. By Animal Type
10.3.3.2.4. By End-use
11. Market Dynamics
11.1. Drivers
11.2. Challenges
12. Market Trends & Developments
12.1. Merger & Acquisition (If Any)
12.2. Product Launches (If Any)
12.3. Recent Developments
13. Global Animal Biotechnology Market: SWOT Analysis
14. Porter's Five Forces Analysis
14.1. Competition in the Industry
14.2. Potential of New Entrants
14.3. Power of Suppliers
14.4. Power of Customers
14.5. Threat of Substitute Products
15. Competitive Landscape
15.1. Zoetis Inc
15.1.1. Business Overview
15.1.2. Products & Services
15.1.3. Recent Developments
15.1.4. Key Personnel
15.1.5. SWOT Analysis
15.2. Boehringer Ingelheim GmbH
15.3. Biogenesis Bago SA
15.4. Merck & Co., Inc.
15.5. Virbac SA
15.6. Elanco LLC
15.7. IDEXX Laboratories Inc
15.8. Heska Corp
15.9. Indian Immunologicals Ltd
15.10. Hester Biosciences Limited
16. Strategic Recommendations
17. About Us & Disclaimer
提及公司
同分類最新報告（醫療與生命科學）
常見問題
這份報告可以先索取樣本嗎？
可以。建議購買前先申請樣本，提出申請後約 2 個工作天內提供，您可以先確認內容涵蓋範圍是否符合需求。
報告價格如何計算？
報告以美元標價，台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本（單人／多人／企業全站）價格不同，量子訊息會評估您的使用情境後提供最優惠報價。
下單後多久交付？如何付款？
一般 3–7 個工作天交付，實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票，30 天內電匯付款即可。
量子訊息有限公司為 TechSci Research 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們